Literature DB >> 19957372

Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry.

Tao Sun1, Nan Zhao, Xiu-Lan Zhao, Qiang Gu, Shi-Wu Zhang, Na Che, Xing-Hui Wang, Jing Du, Yi-Xin Liu, Bao-Cun Sun.   

Abstract

UNLABELLED: The up-regulation and nuclear relocation of epithelial-mesenchymal transition (EMT) regulator Twist1 have been implicated in the tumor invasion and metastasis of human hepatocellular carcinoma (HCC). The term vasculogenic mimicry (VM) refers to the unique capability of aggressive tumor cells to mimic the pattern of embryonic vasculogenic networks. However, the relationship between Twist1 and VM formation is not clear. In this study, we explored HCC as a VM and EMT model in order to investigate the role of Twist1 in VM formation. We first examined the expression of Twist1 in human HCC samples and cell lines and found that Twist1 was frequently overexpressed in the nuclear relocation occurring in VM-positive HCCs (13/18 [72%]). Twist1 nuclear expression was likewise significantly associated with VM formation. Clinicopathological analysis revealed that both VM and Twist1 nuclear expressions present shorter survival durations than those without expression. We consistently demonstrated that an overexpression of Twist1 significantly enhanced cell motility, invasiveness, and VM formation in an HepG2 cell. Conversely, a knockdown of Twist1 by the short hairpin RNA approach remarkably reduced Bel7402 cell migration, invasion, and VM formation. Using chromatin immunoprecipitation, we also showed that Twist1 binds to the vascular endothelial (VE)-cadherin promoter and enhances its activity in a transactivation assay.
CONCLUSION: The results of this study indicate that Twist1 induces HCC cell plasticity in VM cells more through the suppression of E-cadherin expression and the induction of VE-cadherin up-regulation than through the VM pattern in vivo and in a three-dimensional in vitro system. Our findings also demonstrate a novel cogitation in cancer stem-like cell differentiation and that related molecular pathways may be used as novel therapeutic targets for the inhibition of HCC angiogenesis and metastasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19957372     DOI: 10.1002/hep.23311

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  161 in total

1.  Epithelial-mesenchymal transitions and hepatocarcinogenesis.

Authors:  Janice Jou; Anna Mae Diehl
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

2.  Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma.

Authors:  Yuan Cheng; Lei Luo; Juqiang Zhang; Mantian Zhou; Yujun Tang; Guolin He; Yishi Lu; Zhong Wang; MingXin Pan
Journal:  J Gastrointest Surg       Date:  2019-02-25       Impact factor: 3.452

3.  Sox2 expression predicts poor survival of hepatocellular carcinoma patients and it promotes liver cancer cell invasion by activating Slug.

Authors:  Chun Sun; Lu Sun; Yan Li; Xiaonan Kang; Shu Zhang; Yinkun Liu
Journal:  Med Oncol       Date:  2013-02-21       Impact factor: 3.064

4.  2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol reverses EGF-induced cell migration and invasion through down-regulation of MDM2 in breast cancer cell lines.

Authors:  Dayong Zheng; Xing Chang; Yang Liu; Jingwen Xu; Wenfeng Gou; Zengqiang Li; Daiying Zuo; Weige Zhang; Yingliang Wu
Journal:  Cancer Biol Ther       Date:  2018-12-04       Impact factor: 4.742

Review 5.  Epithelial-to-mesenchymal transitions and circulating tumor cells.

Authors:  Arnaud Bonnomet; Anne Brysse; Anthony Tachsidis; Mark Waltham; Erik W Thompson; Myriam Polette; Christine Gilles
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-07       Impact factor: 2.673

6.  Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype.

Authors:  Lingli Yao; Danfang Zhang; Xiulan Zhao; Baocun Sun; Yanrong Liu; Qiang Gu; Yanhui Zhang; Xueming Zhao; Na Che; Yanjun Zheng; Fang Liu; Yong Wang; Jie Meng
Journal:  J Cell Mol Med       Date:  2016-05-31       Impact factor: 5.310

7.  Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications.

Authors:  Dawn A Kirschmann; Elisabeth A Seftor; Katharine M Hardy; Richard E B Seftor; Mary J C Hendrix
Journal:  Clin Cancer Res       Date:  2012-04-02       Impact factor: 12.531

Review 8.  Biomaterials and Culture Systems for Development of Organoid and Organ-on-a-Chip Models.

Authors:  Katya D'Costa; Milena Kosic; Angus Lam; Azeen Moradipour; Yimu Zhao; Milica Radisic
Journal:  Ann Biomed Eng       Date:  2020-04-13       Impact factor: 3.934

9.  Immature myeloid cells are critical for enhancing bone fracture healing through angiogenic cascade.

Authors:  Seth Levy; Joseph M Feduska; Anandi Sawant; Shawn R Gilbert; Jonathan A Hensel; Selvarangan Ponnazhagan
Journal:  Bone       Date:  2016-09-21       Impact factor: 4.398

10.  MEK/ERK pathway is positively involved in hypoxia-induced vasculogenic mimicry formation in hepatocellular carcinoma which is regulated negatively by protein kinase A.

Authors:  Bin Huang; Enhua Xiao; Manping Huang
Journal:  Med Oncol       Date:  2014-12-09       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.